Chicago, IL – October 19, 2022 – Berkadia announced today the addition of Managing Directors Eric Lee and Chris Lashmet, who will be joining the company’s newest specialty group, Medical & Life Sciences, alongside Senior Managing Director and Head of Medical & Life Sciences Sabrina Solomiany.
“The combined skillset and experience of Sabrina, Eric and Chris will make Berkadia Medical & Life Sciences an immediate force in the healthcare real estate space,” said SVP and Deputy Head of Investment Sales Mike Miner. “With a combined $2.5 billion in closed transactions, Chris and Eric will immediately bolster the team and scale our capabilities in healthcare, with a focus on finding unique real estate and capital markets solutions for clients.”
“We’re thrilled to be bringing on Eric and Chris who have an excellent reputation and track record in our industry. They bring creative deal structuring and unparalleled execution capabilities from their time as principal investors at Ventas and MedProperties Group,” said Solomiany. “Our clients will experience first class service with our strengths as a team combined with Berkadia’s tools and resources. With them on board, I’m confident we’ll have a best-in-class healthcare platform for many years to come.”
Prior to Berkadia, Lee and Lashmet co-led the Medical Office group at Blueprint Healthcare Real Estate Advisors. Together, they founded the new division at Blueprint, grew a team, and experienced significant early success in the market. They closed 20 medical office transactions valued at $170 million during their tenure at Blueprint across various deal profiles, spread throughout the country.
Prior to Blueprint Healthcare Real Estate Advisors, Lee worked on the investments team at Ventas, where he underwrote over $15 billion and closed more than $1 billion of healthcare real estate transactions. Lee’s transaction experience includes medical office buildings, senior housing communities and life sciences buildings. Lee also has experience in ground-up development transactions and redevelopment projects within all three asset classes. Lee also managed a 50-property MOB portfolio and co-led the dispositions process for Ventas. Lee received his bachelor’s degree in Finance and Accounting from the Carlson School of Management at the University of Minnesota and is currently pursuing an MBA at Northwestern’s Kellogg School of Management.
Prior to Blueprint Healthcare Real Estate Advisors, Lashmet worked on the investments teams at Ventas REIT and MedProperties Group, where he focused on acquisitions and development of medical office buildings, life science and senior housing profiles. Before Lashmet started his business career, he was drafted by the Pittsburgh Pirates in 2011 where he played professional baseball for three seasons. Lashmet received his bachelor’s degree in Economics and Business from Northwestern University. He is still involved at the university as an NU For Life Purple Mentor.
The Medical & Life Sciences team provides comprehensive solutions for the various specialties of healthcare real estate including medical office buildings, life sciences, hospitals, surgery centers, post-acute care and behavioral health facilities.
About Berkadia®:
Berkadia, a joint venture of Berkshire Hathaway and Jefferies Financial Group, is a leader in the commercial real estate industry, offering a robust suite of services to our multifamily and commercial property clients. Through our integrated mortgage banking, investment sales and servicing platform, Berkadia delivers comprehensive real estate solutions for the entire life cycle of our clients’ assets.
To learn more about Berkadia, please visit www.berkadia.com.
###
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
